Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

News Industry News TCT 2016

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

November 01, 2016

News Industry News

Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease

September 12, 2016

News Industry News

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

February 17, 2016

News Industry News

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

November 04, 2015

News Industry News

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

October 13, 2015

News Industry News

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

October 13, 2015

News Industry News

Miracor Medical Systems Launches PiCSO® Impulse System in Asia

September 21, 2015

News Industry News

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

September 10, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Industry News

Zebra Technologies Introduces Smart, Non-Invasive Way for Hospitals to Track, Provide Real-Time Feedback on Patients with Acute Myocardial Infarction

August 26, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Industry News

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

July 23, 2015

News Industry News

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

Advertisement

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

Miracor Medical Systems Launches PiCSO® Impulse System in Asia

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

Zebra Technologies Introduces Smart, Non-Invasive Way for Hospitals to Track, Provide Real-Time Feedback on Patients with Acute Myocardial Infarction

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content